Please login to the form below

Not currently logged in
Email:
Password:

Survey reveals need for MS work support

A survey commissioned by Merck Serono for World Multiple Sclerosis Day has revealed the need for support from employers and physicians to make continued employment a viable option for people with MS

A survey commissioned by Merck Serono for World Multiple Sclerosis Day (May 25) has revealed the need for support from employers and physicians to make continued employment a viable option for people with multiple sclerosis (MS).

The Consider MS survey, which involved neurologists and people living with MS in France, Germany, Italy, Spain and the UK, is a response to the Multiple Sclerosis International Federation's (MSIF) theme for World Multiple Sclerosis Day - the relationship between MS and the workplace.

Results of the survey identified a need for greater awareness about the condition, with 80 per cent of people with MS saying they needed more support from their employers than they were currently getting in order to continue working.

They believed greater dialogue about the condition was also needed, with half of people with MS surveyed saying they wanted more support from their healthcare professional on discussing MS with their employer.

"This survey reveals the important role employers and healthcare professionals could have in making this a possibility for people with multiple sclerosis," said Pieter van Galen, an MS patient who was diagnosed five years ago. "And it is simple to do:  I call on all employers to consider making working hours flexible, ensuring offices are accessible and even just making sure parking is easy and close."

Find out more about World Multiple Sclerosis Day.

25th May 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite Digital

We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...